Hiroko Ikeda

Adjunctive everolimus therapy for treatment-resistant focal-onset seizures associated with tuberous sclerosis (EXIST-3): a phase 3, randomised, double-blind, placebo-controlled study

Jacqueline A. French, John A. Lawson, Hiroko Ikeda et al. · The Lancet · 2016 · 728 citations · Full text

HLA-B Locus in Japanese Patients with Anti-Epileptics and Allopurinol-Related Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis

Nahoko Kaniwa, Yoshiro Saito, Michiko Aihara et al. · Pharmacogenomics · 2008 · 404 citations

Light quality affects flavonoid biosynthesis in young berries of Cabernet Sauvignon grape

Kazuya Koyama, Hiroko Ikeda, Puspa Raj Poudel et al. · Phytochemistry · 2012 · 273 citations

Light Quality, Biosynthesis, Engineering +7

<i>HLA‐B*1511</i> is a risk factor for carbamazepine‐induced Stevens‐Johnson syndrome and toxic epidermal necrolysis in Japanese patients

Nahoko Kaniwa, Yoshiro Saito, Michiko Aihara et al. · Epilepsia · 2010 · 229 citations · Full text

A whole-genome association study of major determinants for allopurinol-related Stevens–Johnson syndrome and toxic epidermal necrolysis in Japanese patients

Masahiro Tohkin, Nahoko Kaniwa, Yoshiro Saito et al. · The Pharmacogenomics Journal · 2011 · 183 citations

Toxic Epidermal Necrolysis, Whole-genome Association Study, Genetic Epidemiology +7